This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Natus Medical Inc (BABY)

NASDAQ: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 0.00 32.48M 22.88M 3.88M
Operating Gains/Losses n.a. 2.18M 292.00K 414.00K
Extraordinary Gains / Losses n.a. 0.00 0.00 0.00
(Increase) Decrease In Receivables n.a. -2.43M 9.36M -22.03M
(Increase) Decrease in Inventories n.a. -2.02M -2.30M 5.12M
(Increase) Decrease In Other Current Assets n.a. 0.00 0.00 0.00
(Decrease) Increase In Payables n.a. -7.65M -1.39M 11.31M
(Decrease) Increase In Other Current Liabilities 0.00 9.84M -5.41M -3.08M
(Increase) Decrease In Other Working Capital n.a. -4.44M -6.16M 1.03M
Other Non-Cash Items n.a. 2.43M 6.68M 10.13M
Net Cash From Continuing Operations n.a. 42.14M 36.80M 19.39M
Net Cash From Discontinued Operations n.a. 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0.00 42.14M 36.80M 19.39M
Sale of Property, Plant & Equipment n.a. 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments n.a. 0.00 0.00 0.00
Purchases of Property, Plant & Equipment 0.00 -5.72M -3.70M -7.34M
Acquisitions n.a. -4.92M -18.60M -55.12M
Purchases of Short-Term Investments n.a. 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0.00 -10.64M -22.30M -62.46M
Issuance of Debt 0.00 0.00 57.38M 36.30M
Cash Used for Financing Activities
Issuance of Capital Stock n.a. 16.21M 8.98M 1.86M
Repayment of Long-Term Debt 0.00 -38.02M -52.23M -4.36M
Repurchase of Capital Stock 0.00 -4.63M 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net n.a. 5.53M 3.11M -381.00K
Net Cash From Financing Activities 0.00 -20.91M 17.25M 33.42M
Effect of Exchange Rate Changes 0.00 -132.00K 1.30M -105.00K
Net Change in Cash & Cash Equivalents 0.00 10.45M 33.05M -9.76M
BABY News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

BABY Natus Medical Inc

Chart of BABY

Analysts Ratings for BABY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET BABY ANALYST REPORT

BABY Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs